[e-drug] South-south collaboration for development of new drugs by developing countries

e-drug
1

E-DRUG: South-south collaboration for development of new drugs by developing countries
-----------------------------------------------------------------------

This is to inform you that my paper, “R&D for development of new drugs for
neglected diseases in India” has been published in the International Journal
of Technology and Globalisation, Vol 5, No 1/2, 2010 (
http://www.inderscience.com/browse/index.php?journalID=104&year=2010&vol=5&issue=1/2).

In the light of the experience of the Indian private sector and the
public-private partnerships initiated in India for the development of new
drugs, the paper explores some policy options and suggests the expansion of
public-private partnerships to include organizations from other innovative
developing countries such as Brazil and China. Such south-south cooperation
can provide both the pull and the push incentives and reduce the dependence
on developed country markets and on MNCs for the development of new drugs.

Comments and suggestions are most welcome. Those unable to access the paper
may please write to me for a copy.

Sudip Chaudhuri

Sudip Chaudhuri
Professor of Economics
Indian Institute of Management Calcutta
"Sudip Chaudhuri" <sudip1953@gmail.com>
Other email: sudip@iimcal.ac.in

2

E-DRUG: New analysis of GAVI-AMC funding crisis & R&D costs
--------------------------------------------------

Dear Colleagues,

Here is a new policy analysis of how GAVI and its surplus-contract AMC got into such trouble and what to do about it. Plus comments by prominent others:

SAVING THE PNEUMOCOCCAL AMC – AND GAVI. Human Vaccines 2011;7:1-4 http://www.landesbioscience.com/journals/vaccines/article/14919/ Then download PDF.

COMMENTS BY OTHERS Human Vaccines, March 2011 isssue
http://www.landesbioscience.com/journals/vaccines/toc/volume/7/issue/3/

Here is an analysis of how the cost of R&D has been inflated many times a realistic estimate:

DEMYTHOLOGIZING THE HIGH COST OF R&D FOR DRUGS
http://gooznews.com/?p=2520

If you type the title into a search engine, you will find a link to the article.

With best regards,
Donald

Donald W. Light
Cell: 609-216-0071
Professor, UMDNJ-SOM
Lokey visiting professor, Stanford University
Visiting researcher, CMD, Princeton University
Donald Light <dlight@princeton.edu>